AstraZeneca-Merck’s Lynparza wins approval in China for ovarian cancer treatment, Reuters Dec 5, 2019 The approval in China is based on the results from a late-stage study in which Lynparza lowered the risk of disease progression or…
AstraZeneca’s Tagrisso helps lung cancer patients live longer: study Reuters Aug 9, 2019 The British drugmaker announced overall positive survival results from the study in patients with epidermal growth factor…
